Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Stay informed and receive company updates straight to your inbox.